- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02722707
Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX
December 27, 2018 updated by: Paul D Pettit, Mayo Clinic
Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX. A Humanitarian Use Device ( HUD), Which Has Recently Received a Humanitarian Device Exemption (HDE) From the Food and Drug Administration ( FDA)
This registration is for clinical use of the FENIX, a Humanitarian Use Device (HUD) for fecal incontinence.
This device is indicated for the treatment of fecal incontinence in patients who are not candidates for or have previously failed conservative treatment and less invasive therapy options (e.g.
bulking agents, radiofrequency ablation, sacral nerve stimulation).
Study Overview
Status
No longer available
Conditions
Intervention / Treatment
Detailed Description
The FENIX is surgically placed.
This surgery could be an outpatient procedure or at most an overnight stay in the hospital.
The design of the device allows it to be effective immediately.
The device is similar to the LINX device used for esophageal reflux.
It is a circular set of magnets which surrounds the ano-rectal support.
The size of the device is determined at the time of surgery so that the ano-rectum is closed.
When the patient strains at stool, this pressure separates the magnets and allows passage of stool.
The magnets are held together by an independent malleable titanium wire.
Once straining at stool stops, the magnets are able to re-connect or close the rectum.
We will monitor patients for postoperative complications related to surgery.
Study Type
Expanded Access
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic in Florida
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- non-pregnant female patients
- 18 years of age or older with fecal incontinence
- failed conservative therapy ( pelvic floor physical therapy, medications) and failed trial of interstim.
Exclusion Criteria:
- patients less than 18 years of age,
- pregnant
- previous radiation to pelvis,
- chronic diarrhea or inflammatory bowel disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Paul D Pettit, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
February 26, 2016
First Submitted That Met QC Criteria
March 24, 2016
First Posted (ESTIMATE)
March 30, 2016
Study Record Updates
Last Update Posted (ACTUAL)
December 31, 2018
Last Update Submitted That Met QC Criteria
December 27, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-000150
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fecal Incontinence
-
Alviv Ltd.RecruitingFecal Incontinence (FI)Israel
-
RDD Pharma LtdWithdrawnIdiopathic Fecal IncontinenceIsrael
-
Batterjee Medical CollegeBenha UniversityCompleted
-
Hospital de MataróCompletedHealthy Female Volunteer | Fecal Incontinence (FI)Spain
-
Badr UniversityCompletedFecal Incontinence in ChildrenEgypt
-
Hospital Mutua de TerrassaCompletedGas Incontinence | Soilings, Fecal
-
Nantes University HospitalCompletedConstipation Aggravated | Fecal Incontinence With Fecal UrgencyFrance
-
Assiut UniversityRecruiting
-
Queen Mary University of LondonCompletedBowel Incontinence | Faecal Incontinence
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedFecal Incontinence | Bowel IncontinenceUnited States
Clinical Trials on magnetic anal sphincter augmentation for fecal incontinence
-
Torax Medical IncorporatedCompletedFecal Incontinence | Faecal IncontinenceFrance, Germany
-
Torax Medical IncorporatedCompletedFecal IncontinenceUnited States, Denmark, France
-
Torax Medical IncorporatedCompletedGastroesophageal RefluxUnited States, Netherlands
-
Foregut Research FoundationTerminatedHiatal Hernia Large | Gastro Esophageal Reflux | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Reflux, Gastroesophageal | Reflux AcidUnited States
-
ASTORA Women's HealthCompletedFecal IncontinenceUnited States
-
Melanie Salerno, RNLifespanUnknown
-
Nantes University HospitalSuspendedFecal Incontinence | Anal IncontinenceFrance
-
US Department of Veterans AffairsTerminated
-
The Heartburn FoundationActive, not recruitingHiatal Hernia | Gastroesophageal Reflux DiseaseUnited States
-
Felix GutierrezHospital Clinic of Barcelona; Hospital General Universitario Elche; Germans Trias... and other collaboratorsRecruiting